Visa Inc. Chief Executive Officer Ryan McInerney executed a planned stock transaction on August 21, 2026, selling 5,875 shares of Class A common stock for $2.16 million and exercising 5,875 employee stock options at $134.76 per share.
The sales and exercises were conducted under a Rule 10b5-1 trading plan established on May 22, 2026. The Class A shares were sold at $367.87 each, while the options were acquired at the grant price of $134.76 per share, with a total acquisition cost of $791,715. The options were originally granted on November 19, 2018, and vest in three equal installments on the first three anniversaries of the grant date, expiring on November 19, 2028.
Following the transactions, McInerney holds 15,174 shares directly and 265,168 shares indirectly through the Ryan and Angela McInerney Trust. Additionally, he retains 64,624 unexercised employee stock options. Visa’s Class A stock was trading at $382.41, 1% below its 52-week high of $383.43.
Visa also addressed a compliance matter involving Hims & Hers Health, which was placed in the company’s Acquirer Monitoring Program due to a surge in customer credit card disputes linked to its weight-loss subscription business. The disputes incur an $8 surcharge per incident, with Hims & Hers facing an estimated bill of nearly $75,000. Visa’s payment network, VisaNet, remains central to its operations, while partners such as Repay Holdings Corporation collaborate to resell Visa Platform Connect, offering direct access to Visa’s payment solutions ecosystem.
Analysts maintained mixed outlooks on Visa’s valuation. Piper Sandler raised the company’s price target to $430 with an Overweight rating, citing growth potential in artificial intelligence. Bernstein, however, projected that Mastercard might modestly outperform Visa in revenue growth by 2027, particularly in value-added services. Bank of America noted that July retail sales, excluding autos, were expected to decline 0.4% due to the shift of Amazon’s Prime Day promotions from July to June.
